GLP-1RAs have been shown to improve liver health in patients with NAFLD and type 2 diabetes, as well as non-alcoholic steatohepatitis (NASH) [13, 29]
Seek prompt medical attention for severe abdominal pain, repeated vomiting, fainting, allergic reaction symptoms, or signs of dehydration
TIRZEPATIDE is a groundbreaking dual-action molecule that activates the body's GIP and GLP-1 receptorsnatural incretin hormones critical for appetite regulation and fat metabolism
Game changer for our relationship. My partner and I are both on it: no change
Medicare covers GLP-1s for $50/month starting July 2026 For decades, a legal exclusion blocked Medicare from covering drugs used for anorexia, weight loss, or weight gain. That sentence is the reason a Medicare beneficiary with a BMI of 38 could not get Wegovy through their drug plan (unless they also had established cardiovascular disease)
Weekly dosing produces sustained GHRH signalling (not pulsatile)